Cost savings of biosimilars in oncology: A single institution experience.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.29_suppl.10
Abstract: 10Background: Biosimilar medications have increasingly gained regulatory approvals in recent years. Numerous conditions in the fields of hematology, oncology, rheumatology, and endocrinology have a... read more here.
Keywords: oncology single; savings biosimilars; oncology; single institution ... See more keywords